EP3551294
IMPROVED NK-BASED CELL THERAPY
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
11.12.2017EP published:
16.2.2022EP application number:
17825416.5
EPO information:
European Patent Register
Max expiry date:
10.12.2037
Title in English:
IMPROVED NK-BASED CELL THERAPYLanguage of the patent:
English
Timeline
Today
11.12.2017EP application
16.2.2022EP Publication
Owner
Name:
ONK Therapeutics LimitedAddress:
C/O Coll & Company Pier Road Barna Village, Co. Galway H91 V6KV, IE
Inventor
Name:
O'DWYER, Michael Eamon PeterAddress:
Galway, IE
Name:
HU, JinsongAddress:
Xi'an Shaanxi, CN
Priority
Number:
201662432334 PDate:
9.12.2016Country:
US
Number:
17179414Date:
3.7.2017Country:
EP
Classification
Categories:
A61P 35/00, C07K 16/24, A61K 31/00, A61K 35/17, C07K 14/00, C12N 15/113, A61K 39/395